Figure 5. Protective effect of recombinant TM-1 immunization
against MG challenge . Clinical severity was observed and recorded for
two weeks after MG challenge. Score categories were assigned according
to the description in materials and methods section in text. *,P <0.05, **, P <0.01, ***,P <0.001.